Bulltick Wealth Management, LLC

Position in NVO — Novo Nordisk A S

CIK 1912448 Miami, FL

Position in NVO

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$4,126,675

+$965,073 QoQ

Shares Held

86,080

+0.1% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

1.28%

of 13F equity value

Holder Rank

#243

of 1,348 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Bulltick Wealth Management, LLC holds $6,663,418 across 7 Drug Manufacturers - General names. NVO ranks #1 (61.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NVO	Novo Nordisk A S This page	86,080	$4,126,675
2	LLY	ELI LILLY & Co	660	$791,623
3	PFE	Pfizer Inc	21,389	$515,047
4	ABBV	AbbVie Inc.	1,699	$427,536
5	JNJ	Johnson & Johnson	1,314	$333,716
6	SNY	Sanofi	7,509	$320,333
7	GRFS	Grifols SA	20,973	$148,488

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,126,675	86,080	+0.1%	Shares	Sole	2026-07-30
2026-03-31	$3,161,602	86,030	-18.6%	Shares	Sole	2026-04-27
2025-12-31	$5,380,152	105,742	-33.0%	Shares	Sole	2026-02-17
2025-09-30	$8,761,205	157,888	+159.0%	Shares	Sole	2025-11-13
2025-06-30	$4,207,252	60,957	+1430.4%	Shares	Sole	2025-08-11
2025-03-31	$276,579	3,983	-39.2%	Shares	Sole	2025-05-13
2024-12-31	$563,258	6,548	-79.0%	Shares	Sole	2025-02-14
2024-09-30	$3,714,745	31,198	—	Shares	Sole	2024-11-14
No filing history on record for this holder in this stock.